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Mammalian cells respond to DNA double-strand breaks (DSBs) by
recruiting DNA repair and cell-cycle checkpoint proteins to such
sites. Central to these DNA damage response (DDR) events is the
DNA damage mediator protein MDC1. MDC1 interacts with
several DDR proteins, including the MRE11–RAD50–NBS1
(MRN) complex. Here, we show that MDC1 is phosphorylated
on a cluster of conserved repeat motifs by casein kinase 2 (CK2).
Moreover, we establish that this phosphorylation of MDC1
promotes direct, phosphorylation-dependent interactions with
NBS1 in a manner that requires the closely apposed FHA and twin
BRCT domains in the amino terminus of NBS1. Finally, we show
that these CK2-targeted motifs in MDC1 are required to mediate
NBS1 association with chromatin-flanking sites of unrepaired
DSBs. These findings provide a molecular explanation for the
MDC1–MRN interaction and yield insights into how MDC1
coordinates the focal assembly and activation of several DDR
factors in response to DNA damage.
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INTRODUCTION
To counter the threat to the genome from DNA-damaging agents,
cells use the DNA damage response (DDR): a set of events
involving activation of DNA repair mechanisms and cell-cycle
‘checkpoint’ signalling (Kastan & Bartek, 2004). DNA double-
strand breaks (DSBs)—the most cytotoxic DNA lesions—activate
the protein kinase ataxia telangiectasia mutated (ATM) to phos-
phorylate the carboxy-terminal tail of histone H2AX in the vicinity
of the break (Stucki & Jackson, 2006). This chromatin modification
is crucial for the relocalization of several proteins to sites flanking
DSBs, generating ionizing radiation-induced foci (IRIF) that
promote efficient repair and sustained DNA damage signalling
(Fernandez-Capetillo et al, 2004; Stucki & Jackson, 2006).
A core IRIF component is the mediator of the DNA-damage
checkpoint protein 1 (MDC1; Goldberg et al, 2003; Lou et al,2 0 0 3 ;
Stewart et al, 2003; Stucki et al, 2005). MDC1 colocalizes with
phospho-H2AX (gH2AX) owing to direct interactions between the
C-terminal twin BRCT (BRCT2) domains of MDC1 and the gH2AX
phospho-epitope (Stucki et al,2 0 0 5 ) .M D C 1t h e nm e d i a t e sI R I F
formation by other DDR factors such as p53 binding protein 1
(53BP1), breast cancer protein 1 (BRCA1) and the MRE11–RAD50–
NBS1 (MRN) complex (Goldberg et al, 2003; Stewart et al,2 0 0 3 ) .
We and others have recently shown that a cluster of repeated
consensus ATM phosphorylation sites in MDC1 is crucial for the
recruitment of BRCA1 and 53BP1 to IRIF, but not for NBS1 focus
formation (Huen et al, 2007; Kolas et al, 2007; Mailand et al, 2007).
On phosphorylation, these motifs are bound by the FHA domain of
the ubiquitin E3 ligase ring-finger protein 8 (RNF8), which then
generates ubiquitin conjugates at sites of DSBs that mediate BRCA1
and 53BP1 recruitment. Although MDC1 was shown to directly
bind to MRN some years ago (Goldberg et al, 2003), the molecular
basis of how MDC1 recruits MRN to IRIF has remained elusive.
Here, we show that a cluster of repeated motifs in MDC1, which
are phosphorylated by casein kinase 2 (CK2), are bound by MRN
through phospho-dependent interactions with NBS1 that require its
amino-terminal FHA and BRCT2 domains. Furthermore, we show
that this MDC1–NBS1 interaction is crucial for the targeting and
retention of NBS1 on chromatin-flanking DNA DSBs.
RESULTS
Phosphorylated SDTD repeats of MDC1 bind to MRN
A search of published databases for the post-translational
modifications of MDC1 identified many phosphorylation sites;
however, two studies (Beausoleil et al, 2004; Olsen et al, 2006)
identified eight sites within a cluster of short-repeat sequences that
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795shared the consensus motif Ser-Asp-Thr-Asp (SDTD) in which both
the serine and threonine are phosphorylated. This SDTD motif is
repeated six times between Ser218 and Asp455 in human MDC1,
and similar evolutionarily conserved motifs exist in MDC1
orthologues in other vertebrates (Fig 1A).
To investigate whether the SDTD motifs might interact with
other DDR components, we generated a synthetic peptide that
corresponded to MDC1 residues 325–340 bearing dual phosphor-
ylation on Ser329 and Thr331. This peptide and its unphos-
phorylated equivalent were coupled to beads and used to retrieve
interacting proteins from HeLa cell nuclear extracts. This
approach identified four prominent protein bands on a silver-
stained gel that bound in a phosphorylation-dependent manner
(Fig 1B). Mass spectrometric analysis identified three of these as
MRE11, RAD50 and NBS1. We noted that control binding assays
with the gH2AX phospho-peptide retrieved MRN and MDC1 from
nuclear extracts, whereas the phosphorylated SDTD peptide
bound MRN only (Fig 1C). This indicates that the phosphorylated
MDC1 SDTD peptide does not interact with MRN indirectly by
bridging contacts with MDC1.
CK2 phosphorylation of MDC1 mediates MRN binding
To study phosphorylation of the MDC1 SDTD region and to
investigate its regulation, we raised a rabbit polyclonal antiserum
against a synthetic peptide corresponding to one of the MDC1
SDTD repeats phosphorylated on Ser329 and Thr331 (supple-
mentary Fig S1A online). This detected MDC1 isolated from
HeLa nuclear extracts, indicating that MDC1 S329/T331 phos-
phorylation is present in proliferating human cells (Fig 2A, left
panels). The signal from this antibody was lost when MDC1
precipitated with gH2AX peptide-coupled beads was treated with
phosphatase, confirming its phospho-specificity (Fig 2A, left
panels; detection of RAD50 indicates equal protein loading).
Interestingly, although g-irradiation of osteosarcoma (U2OS) cells
caused little change in the amount of MDC1 S329/T331
phosphorylation, it reduced the overall levels of MDC1 (Fig 2A,
right panels). This suggests that, after DNA damage, S329/T331-
phosphorylated MDC1 is more stable than the unmodified
protein. Consistent with these data, S329/T331-phosphorylated
MDC1 was detected by immunofluorescence in both control and
g-irradiated cells (Fig 2B; note the absence of staining in cells
treated with MDC1 small interfering RNA (siRNA)), confirming
that SDTD-phosphorylated MDC1 is present in the absence of
damage and also forms IRIF. Notably, we did not detect any cell-
cycle-dependent alteration of MDC1 S329/T331 phosphorylation
relative to total MDC1 protein content by using flow cytometry,
which suggests that SDTD phosphorylation occurs throughout
interphase (supplementary Fig S1B online).
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Fig 1 |Phosphorylated MDC1 SDTD motifs bind to MRN. (A) Domain architecture of MDC1 and alignment of the SDTD region from MDC1 proteins in
human (hMDC1), chimpanzee (ptMDC1), pig (ssNFBD1), dog (cfMDC1) and mouse (mmMDC1). RBM indicates RNF8-binding motifs. Identical and
similar residues are boxed in black and grey, respectively. CK2 consensus sites are underlined, and residues identified as phosphorylated (Beausoleil et al,
2004; Olsen et al, 2006) are numbered (0phosphorylated residues identified in both studies). (B) Silver-stained SDS–polyacrylamide gel of an SDTD
peptide pull-down. PP, S329 T331 doubly phosphorylated peptide and  , its non-phosphorylated equivalent; B, bead-interacting proteins removed from
extracts in a pre-clearing step; M, molecular weight markers. (C) Immunoblot of SDTD and histone H2AX phosphopeptide-interacting proteins. INP,
input (5% of total); g, phosphorylated H2AX peptide. CK2, casein kinase 2; MRN, MRE11–RAD50–NBS1; SDTD, Ser–Asp–Thr–Asp motif.
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796The MDC1 SDTD motif does not conform to consensus
sequences targeted by ATM or other DDR kinases. Instead, both
the serine and threonine residues in the SDTD sequence match the
CK2 consensus motif of phosphorylated serine/threonine followed
by an acidic residue at the þ3 position (p[S/T]xxD/E). Consistent
with this, a bacterially expressed protein (glutathione S-transferase
(GST)-SDTD2) encompassing two MDC1 SDTD motifs (contained
within amino-acid residues 296–340 of MDC1) was efficiently
phosphorylated by recombinant CK2 in vitro, as shown by a
marked decrease in electrophoretic mobility and detection by
anti-MDC1 pS329/pT331 antiserum (Fig 2C, upper and lower
panels, respectively). By contrast, the equivalent protein bearing
alanine substitutions of Thr301 and Thr331 (GST-SDAD2), while
being phosphorylated by CK2 to some degree (presumably on CK2
consensus serine residues retained in the SDAD motifs present in
this fusion protein), was detected only weakly with the anti-MDC1
pS329/pT331 antiserum (Fig 2C). Moreover, although CK2-mediated
phosphorylation of the GST-SDTD2 protein allowed it to retrieve
MRN from HeLa nuclear extracts, the CK2-treated GST-SDAD2
mutant protein was unable to bind to MRN (Fig 2D).
To investigate whether CK2 phosphorylation of the MDC1
SDTD region promotes MRN binding in vivo, we transiently
expressed a haemagglutinin (HA)-tagged MDC1 SDTD fragment
coupled to a nuclear localization sequence in U20S cells
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Fig 2 |Casein kinase 2-dependent phosphorylation of MDC1 SDTD motifs induces interaction with MRN. (A) Left panels: SDTD peptide interacting
proteins, isolated from HeLa nuclear extracts (as in Fig 1C), were subjected to phosphatase or mock treatment, and then analysed with the indicated
antibodies. Right panels: whole-cell extracts (WCE) from osteosarcoma (U2OS) cells 1h after 5Gy irradiation or control cells were immunoblotted with
the indicated antibodies. (B) At 72h after control (CNTL) or MDC1-targeting siRNA, control cells or cells incubated for 2h following 5Gy of X-rays
were processed for immunofluorescence with MDC1 and MDC1 pS329pT331 antibodies. (C) Immunoblot analysis of purified GST-SDTD2 and GST-
SDAD2 after in vitro phosphorylation by recombinant CK2, or mock treatment. (D) A 250ng portion of purified GST-SDTD2 or GST-SDAD2 was mock
treated or phosphorylated by CK2 in vitro and then incubated with HeLa nuclear extracts. GST fusions and interacting proteins were captured on
glutathione-Sepharose beads and immunoblotted. (E) Expression plasmids encoding HA-SDTD6 were transfected into U2OS cells. After 48h, cells were
treated with 4,5,6,7-tetrabromo-benzimidazole (TBB; 75mM; Sigma-Aldrich (Poole, Dorset, UK), T0826) or dimethyl sulphoxide (DMSO) for 6h.
Extracts were immunoprecipitated (IP) with monoclonal antibodies against HA or GFP (CNTL) and immunoblotted. CK2, casein kinase 2; DAPI,
40,6–diamidino–2–phenylindole; GFP, green fluorescent protein; GST, glutathione S-transferase; HA, haemagglutinin; INP, input; MRN,
MRE11–RAD50–NBS1; SDAD, Ser–Asp–Ala–Ser motif; SDTD, Ser–Asp–Thr–Asp motif; siRNA, small interfering RNA.
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797(HA-SDTD6; supplementary Fig S1C online). Immunoblotting
showed that treating these cells with the CK2 inhibitor 4,5,6,7-
tetrabromo-benzimidazole increased the electrophoretic mobility
of the MDC1 SDTD fragment and reduced the ability of the
fragment to co-immunoprecipitate MRN (Fig 2E).
NBS1 directly binds to CK2-phosphorylated MDC1
Next, we used the recombinant, purified MRN complex in peptide
pull-down experiments. These showed that MRN bound to the
phosphorylated but not the unphosphorylated form of the SDTD
peptide—confirming the direct nature of the interaction—yet did
not bind to either version of the H2AX C-terminal peptide (Fig 3A).
This indicates the specificity of MRN for the phosphorylated
MDC1 SDTD motif and also shows that if, as previously reported,
NBS1 binds to gH2AX directly (Kobayashi et al, 2002), this
interaction must be less stable than MRN binding to the
phosphorylated SDTD motif.
Within MRN, only NBS1 contains phosphorylation-specific
interaction domains: an N-terminal FHA domain followed directly
by a BRCT2 domain (Durocher et al, 2000; Manke et al, 2003; Yu
et al, 2003; Becker et al, 2006). To investigate whether these
domains bind to the phosphorylated SDTD motif of MDC1, we
expressed an N-terminal fragment of NBS1 containing these motifs
(residues 1–343; HA-fNBS1) in rabbit reticulocyte lysates (despite
many attempts using a wide range of expression constructs, we
were unable to express soluble recombinant versions of the FHA
or FHA/BRCT2 domains of NBS1 in bacteria). We also generated
versions of this NBS1 region in which either the FHA domain
(fNBS1R28A and fNBS1H45A) or the BRCT2 region (fNBS1K160M)
was mutated to abolish phospho-dependent interactions. These
proteins were then tested for binding to an MDC1 fragment
encompassing the SDTD repeats (GST-SDTD6) that had or had not
been treated with CK2 (Fig 3B). Significantly, the wild-type NBS1
fragment bound specifically to CK2-phosphorylated—but not
unphosphorylated—GST-SDTD6, whereas this binding was abolished
by mutation of the FHA or BRCT2 domain of NBS1 (Fig 3B).
Furthermore, CK2-phosphorylated GST-SDTD2 retrieved NBS1 and
RAD50 from both MRC5- and NBS1-complemented Nijmegen
breakage syndrome (NBS) cell extracts, but did not mediate such
interactions when the FHA domain mutant of NBS1 was expressed
in NBS cells (Fig 3C; see supplementary Fig S2 online for expression
levels). Taken together, these results indicate that the integrity of
both the FHA and BRCT2 domains of NBS1 is needed for binding of
NBS1 to the phosphorylated SDTD region of MDC1.
MDC1 SDTD motifs retain MRN at DNA DSB sites
An analysis of the recruitment dynamics of fluorescently tagged
proteins to laser-induced DNA damage showed similar recruit-
ment kinetics for NBS1 and MDC1, and highlighted the
importance of the FHA domain of NBS in this recruitment
(Lukas et al, 2004). Therefore, we thought that the MDC1–MRN
interaction, which depends on the FHA/BRCT2 domains of
NBS1, might promote retention of the MRN complex in IRIF. To
test this, we used siRNA to deplete endogenous MDC1 in U2OS
cells stably expressing siRNA-resistant wild-type MDC1
(MDC1WT) or an MDC1 mutant without the SDTD region
(MDC1SDTDD; Fig 4A; supplementary Fig S3A online). The wild-
type MDC1 derivative efficiently co-immunoprecipitated MRN at
physiological salt concentrations, whereas only low levels of MRN
were recovered in immunoprecipitates of the MDC1SDTDD mutant
(Fig 4B), consistent with the SDTD region being the principal
MRN interaction interface. This residual interaction with MRN
shown by the MDC1SDTDD mutant raises the possibility of other
MDC1–MRN interactions, and would be consistent with previous
findings (Goldberg et al, 2003); however, it is noteworthy that this
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Fig 3 |Binding of MRN to MDC1 phospho-SDTD motifs requires the
NBS FHA and BRCT2 domains. (A) MRN interacts directly with
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kinase 2; GST, glutathione S-transferase; HA, haemagglutinin; MRN,
MRE11–RAD50–NBS1; SDTD, Ser–Asp–Thr–Asp motif.
CK2 dependent MDC1–MRN interactions
J.R. Chapman & S.P. Jackson
EMBO reports VOL 9 | NO 8 | 2008 &2008EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
scientificreport
798weaker interaction was undetectable under higher salt conditions
(supplementary Fig S3B online). Moreover, although both
MDC1WT and MDC1SDTDD efficiently formed IRIF, MDC1WT,
but not MDC1SDTDD, supported IRIF formation by NBS1 (Fig 4C;
see supplementary Fig S3C online for quantification). By contrast,
IRIF formation by 53BP1 and BRCA1 was normal after expression
of either form of MDC1 (Fig 4D; supplementary Fig S4A online).
This is consistent with 53BP1 and BRCA1 requiring the
RNF8-binding motifs of MDC1 that are still intact in the
MDC1SDTDD mutant (Fig 4A), and shows that the SDTD region
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Fig 4 |The MDC1 SDTD–MRN interaction recruits NBS1 to damaged chromatin. (A) SDTD deletion relative to the MDC1 domain architecture.
(B) Indicated expression constructs were transfected into human embryonic kidney 293 cells. After 48h, extracts were prepared, immunoprecipitated
(IP) with GFP antibodies and immunoblotted. Immunoprecipitations and washes were performed at 150mM salt; INP, input (5%). (C,D) Indicated
osteosarcoma (U2OS) cell lines were treated with two rounds of control (CNTL) or MDC1-targeting siRNA for 72h. Cells were then treated with
5Gy of X-rays and processed for immunofluorescence 4h later with MDC1, (C) NBS1 or (D) 53BP1 antibodies (non-irradiated cells are shown in
supplementary Fig S4B,C online). (E) U2OS cells stably expressing siRNA-resistant MDC1wt (a) or MDC1SDTDD (b) were treated with siRNA
against MDC1 as above, and then the nuclei were subjected to laser micro-irradiation. After 30min, cells were pre-extracted with detergent, fixed
and immunostained with antibodies against MDC1 and NBS1. Asterisks indicate resistance to MDC1 siRNA. GFP, green fluorescent protein;
MRN, MRE11–RAD50–NBS1; SDTD, Ser–Asp–Thr–Asp motif; siRNA, small interfering RNA.
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799of MDC1 specifically mediates IRIF formation by NBS1 by
promoting efficient MDC1–MRN interactions.
To examine further the NBS1 recruitment defect of cells
expressing MDC1SDTDD, we used the ‘laser scissors’ technique to
generate DNA DSBs along defined sub-micrometre tracks in live
cells (Limoli & Ward, 1993). In MDC1WT-expressing cells, the
extent of NBS1 recruitment closely resembled that of MDC1 (Fig 4Ea).
By contrast, although MDC1SDTDD recruitment was indistinguish-
able from that of the MDC1WT protein, the NBS1 recruitment
pattern was altered. Thus, in MDC1SDTDD cells, although NBS1 was
recruited to the laser path, its pattern no longer resembled the broad
distribution of MDC1; instead, NBS1 was restricted to a discrete
micro-focal pattern lying within the broader track of MDC1 staining
(Fig 4Eb). This indicates that SDTD phosphorylation of MDC1 is
required to retain NBS1 on gH2AX-coupled chromatin, but that
NBS1 might recognize other structures induced by laser micro-
irradiation independently of MDC1. Consistent with these results,
and in line with our finding that the FHA domain of NBS1 is
required for MDC1 SDTD binding, similar micro-focal patterns
of NBS1 recruitment were observed in MDC1-depleted cells
and in cells in which the FHA domain of NBS1 was mutated
(Lukas et al, 2004).
DISCUSSION
MDC1 binds to gH2AX flanking unrepaired DNA DSBs, and then
acts as a ‘mediator’ to recruit other DDR factors to such sites
(Stucki & Jackson, 2006). For example, the ATM-phosphorylated
TQXF motifs on MDC1 are recognized by the ubiquitin E3 ligase
enzyme RNF8 (Huen et al, 2007; Kolas et al, 2007; Mailand et al,
2007). RNF8 then generates ubiquitin adducts on histone H2A—
and possibly other chromatin components—which lead to IRIF
formation by 53BP1 and BRCA1 (Huen et al, 2007; Mailand et al,
2007). This paper describes how MDC1 facilitates the accumula-
tion and retention of the MRN complex in IRIF, indicating a new
mechanism for MDC1 mediator function. Specifically—and in
contrast to the situation for 53BP1 and BRCA1—our work
highlights how phospho-dependent interactions between MDC1
and MRN might precede the detection and signalling of DNA
damage. This characteristic of MDC1–MRN binding might there-
fore allow this complex to be efficiently and rapidly recruited to
sites of DNA damage, thus ensuring that the DDR is launched
without delay. By contrast, the ATM- and RNF8-dependent nature
of 53BP1 and BRCA1 recruitment means that it is likely to happen
more slowly, possibly to ensure that the chromatin alterations and
other processes triggered by these proteins are invoked only at the
right time and in the correct chromatin context. This model—in
which various factors are recruited with different kinetics and
factor dependencies—suggests a more complex, hierarchical and
highly regulated DDR than has hitherto been apparent.
Together with data obtained from proteomics screens (Beau-
soleil et al, 2004; Olsen et al, 2006), our findings indicate that
CK2 phosphorylates several sites on MDC1, often at dual
phosphorylation sites within the SDTD motif. These findings are
in agreement with previous work showing that CK2 has an impact
on various DDR events. For example, it was previously shown that
CK2-dependent phosphorylation of the adaptor/mediator proteins
XRCC1 and XRCC4 promotes the recruitment of polynucleotide
kinase (PNK), Aprataxin, and Aprataxin- and PNK-like factor
(APLF) to sites of chromosomal damage to facilitate the repair of
DSBs and DNA single-strand breaks, respectively (Clements et al,
2004; Loizou et al, 2004; Iles et al, 2007). Interestingly, in these
studies, CK2 was found to mediate factor recruitment through
direct interactions between the CK2 phosphorylation sites on
XRCC1/XRCC4 and the FHA domains of PNK, Aprataxin and
APLF. It is noteworthy that the NBS1 recruitment defects we
observed in MDC1SDTDD mutant cells are similar to those reported
for cells containing NBS1 with mutations in its FHA domain
(Lukas et al, 2004), suggesting that the FHA domain of NBS1 binds
to MDC1. Although our data support this idea, the fact that
mutations in either the FHA or BRCT2 domain of NBS1 impair
the NBS1–MDC1 interaction suggests that both domains are
intimately involved in making such contacts. It might be that these
domains are orientated such that they are able to simultaneously
bind to both the phosphorylated serine and the phosphorylated
threonine of a single SDTD motif, or to two adjacent SDTD motifs
in the MDC1 protein. This dual-interaction mode might provide a
greater degree of binding selectivity and discrimination than
would be possible by phospho-dependent interactions involving
either domain alone. Alternatively, it is possible that the proximity
of the FHA and BRCT2 domains of NBS1 makes them con-
formationally inter-dependent, so that mutation of one affects the
structure and function of the other. The tightly interconnected
FHA/BRCT2 domain architecture is conserved in virtually all
known NBS1 counterparts (Becker et al, 2006), pointing to this
relationship being of crucial functional importance. Resolution of
the above issues will await structural determinations of the N
terminus of NBS1, both alone and in a complex with the
phosphorylated MDC1 SDTD motif.
After DNA damage, we have consistently observed stabiliza-
tion of the CK2-phosphorylated MDC1 relative to the total MDC1
pool, which is downregulated. This is consistent with a recent
study showing 26S proteasome-dependent turnover of the
mediator proteins topoisomerase II binding protein 1 (TOPBP1),
Claspin, 53BP1 and MDC1 following DNA damage (Zhang et al,
2006). Whether CK2 phosphorylation itself, or MRN binding to
the phosphorylated SDTD motifs, protects a sub-pool of MDC1
from proteolytic degradation remains to be determined. It is also
noteworthy that CK2 phosphorylations on XRCC1 mediate binding
to PNK, Aprataxin and APLF (Clements et al, 2004; Loizou et al,
2004; Iles et al, 2007) and, conversely, that FHA domain-
containing proteins such as PNK, Aprataxin and APLF are able
to bind to CK2 phosphorylation sites on both XRCC1 and XRCC4.
This raises the possibility that the phosphorylated SDTD regions of
MDC1 might interact with proteins in addition to NBS1, and that
the FHA/BRCT2 region of NBS1 might have more than one
physiological target.
Finally, a recent study of MDC1-deficient mouse cells
complemented with various MDC1 domain-deletion constructs
showed the central repeat region of MDC1 and FHA and BRCT2
domains are important for DSB repair by sister-chromatid
recombination (Xie et al, 2007). This work also showed that
MDC1-dependent recruitment of BRCA1 and 53BP1 to IRIF was
not required for this repair, or for 53BP1-dependent DSB repair by
non-homologous end-joining. So far, a functional role for the
marked redistribution of DDR factors to regions surrounding DSBs
has not been defined. Perhaps future studies using the MDC1
separation-of-function mutants created in this study will help
to explain the different and possibly overlapping functional
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METHODS
See the supplementary information online for details.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
Note added in proof. While this work was under revision, two
related papers have been published: Melander F, Bekker-Jensen S,
Falck J, Bartek J, Mailand N, Lukas J (2008) Phosphorylation of
SDT repeats in the MDC1 N terminus triggers retention of NBS1 at
the DNA damage-modified chromatin. J Cell Biol 181: 213–226;
Spycher C, Miller ES, Townsend K, Pavic L, Morrice NA,
Janscak P, Stewart GS, Stucki M (2008) Constitutive phos-
phorylation of MDC1 physically links the MRE11–RAD50–NBS1
complex to damaged chromatin. J Cell Biol 181: 227–240.
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